IMB Dx, Inc. services

Analysis of cancer-related genes through blood. Through a simple blood draw, key genes related to various cancer types of solid cancers (including gastric, lung, colon, breast, liver, pancreatic, ovarian and uterine cancer, as well as rare cancers such as melanoma and sarcoma) can be tested for somatic mutations.

The AlphaLiquid® platform is being widely applied in translational research to empower our understanding of tumor evolution, response to therapy and resistance mechanisms, as well as to provide insights on the clinical value of ctDNA analysis in precision oncology.

The AlphaLiquid® platform enables enhanced safety, speed and efficiency in clinical trials for drug development.

Patients with advanced solid tumors may be tested with AlphaLiquid® 100 after consulting with their primary care physician at major general hospitals in Korea.